Reviewers More Likely to Accept Single-Blind Manuscripts

Share this content:
Reviewers More Likely to Accept Single-Blind Manuscripts
Reviewers More Likely to Accept Single-Blind Manuscripts

WEDNESDAY, Sept. 28, 2016 (HealthDay News) -- Reviewers are more likely to accept manuscripts when author names and institutions are visible, even in the presence of errors in the manuscript, according to a study published in the Sept. 27 issue of the Journal of the American Medical Association.

Kanu Okike, M.D., M.P.H., from Kaiser Moanalua Medical Center in Honolulu, and colleagues conducted a study at Clinical Orthopaedics and Related Research, a journal that allows authors to select single-blind or double-blind peer review. Reviewers were randomized to receive single-blind or double-blind versions of a fabricated manuscript, which was putatively written by two past presidents of the American Academy of Orthopaedic Surgeons from prominent institutions, and which included five subtle errors. A total of 119 reviewers completed the review of the manuscript (46 percent).

The researchers observed no significant differences between the single-blind and double-blind groups in sex, nationality, prior reviews completed, or mean time to review completion (all P > 0.05). When the prestigious authors' names and institutions were visible (single-blind review), the reviewers were more likely to recommend acceptance than when the names and institutions were redacted (double-blind review) (87 versus 68 percent; multivariable relative risk, 1.28). Reviewers also gave higher ratings for the methods and other categories in single-blind review. The number of errors detected did not differ.

"Although one study found double-blind reviews to be of higher quality, others detected no differences," the authors write.

Several authors disclosed financial ties to the medical device industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Better Stem Cell Tx Outcomes for Younger MS Patients

Better Stem Cell Tx Outcomes for Younger MS ...

Results support additional trials of autologous hematopoietic stem cell transplantation

OD Risk Up in Children Whose Mothers Are Prescribed Opioids

OD Risk Up in Children Whose Mothers Are ...

Second study finds opioids stored unsafely in many households with children

AAP Urges Doctors Not to Punish Pregnant Women for Opioid Use

AAP Urges Doctors Not to Punish Pregnant Women ...

Group says better prevention and treatment, not jail time, would stem surge in drug-addicted newborns

is free, fast, and customized just for you!

Already a member?

Sign In Now »